Boots have already started the process of recruiting a new Managing Director
Walgreens Boots Alliance (WBA) has officially announced that Sebastian James, the Managing Director of Boots, will be stepping down from his role to pursue a new opportunity in the healthcare sector.
James has given notice to leave the company and will remain with Boots until November. The UK pharmacy giant has already begun the search for a new Managing Director.
James is set to take on the role of CEO at Veonet, a leading European chain of ophthalmology clinics.
During his tenure as Managing Director since 2018, James played a pivotal role in transforming Boots into the UK’s leading health and beauty retailer.
He oversaw significant growth and innovation, achieving thirteen consecutive quarters of retail market share growth. Most recently, the company announced strong Q3 results in June with growth across all categories.
Sebastian contributed to reinventing Boots’ beauty business by introducing hundreds of new brands, refurbishing beauty halls across the UK, and hiring more specialist beauty advisors.
Under his leadership, Boots expanded its healthcare services significantly, now offering over 160 healthcare services to both private and NHS patients.
Ornella Barra, Chief Operating Officer, International at Walgreens Boots Alliance, thanked James for his contributions to the company’s success over the years, stating, “His tenure has seen the company transform through a steadfast focus on investment, innovation, and growth into the No.1 health and beauty destination in the UK.
“We thank Sebastian for his commitment, along with the Boots leadership team, to delivering a strong platform for sustainable, long-term growth, and we wish him all the best for his next endeavor.”
Commenting on his departure, James remarked: “It has been a pleasure to lead this fantastic company and support its transformation during my time as Managing Director.
“Now in its 175th year, Boots has shaped how people access health and beauty products on the high street, and I am proud to have been part of a business that continues to play a critical role in the UK health and beauty sectors.
“I look forward to seeing the business continue to succeed under its excellent leadership team.”
His exit comes as Boots’ parent company, WBA, suspended its plans for a sale or stock market listing of the pharmacy chain.
